FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
758 letters match. Newest first.
-
DrugsLiebel-Flarsheim Company LLC
Liebel-Flarsheim's Raleigh, NC sterile drug plant failed to investigate microbial and endotoxin test failures and let cleanrooms and equipment fall into disrepair.
High risk -
DrugsScientific Protein Laboratories, LLC
FDA warns Scientific Protein Laboratories over manufacturing failures in animal-derived APIs, including equipment particles and inadequate investigations.
High risk -
DevicesRoyal Philips
FDA warns Royal Philips over ultrasound device quality-system failures, including complaint handling and transducers distributed past useful life.
High risk -
BiologicsAllovate Therapeutics, LLC
FDA warned Allovate that its Allerdent allergenic toothpaste is an unapproved drug and lacks a required biologic license.
High risk -
DevicesTechnological Medical Advancements LLC
Technological Medical Advancements LLC marketed Diowave laser systems for unapproved uses without required FDA clearance and had serious quality-system failures.
High risk -
DrugsNaturich Cosmetique Labs
FDA warned Naturich Cosmetique Labs over inadequate manufacturing controls for over-the-counter topical drugs, including contaminated water and untested ingredients.
High risk -
DrugsCreative Essences, Inc.
FDA warns Creative Essences over OTC drug manufacturing failures and an unapproved antiseptic.
High risk -
DrugsPamela K. Den Besten, DDS, MS
FDA warned sponsor-investigator Pamela K. Den Besten for running a pediatric dental gel study without an IND, enrolling 43 subjects.
High risk -
FoodEver Rich Foods LLC
Ever Rich Foods LLC lacked a foreign supplier verification program for imported Indian sweets, FDA says.
Medium -
FoodGracie's Kitchens, Inc.
FDA warns Gracie's Kitchens over Listeria on RTE produce food-contact surfaces and sanitation failures.
High risk -
DrugsRalph A. DeFronzo, M.D.
FDA warns Dr. Ralph A. DeFronzo for enrolling ineligible subjects and failing to promptly report study changes to the IRB.
High risk -
DrugsExpert Aesthetics
FDA warned Expert Aesthetics over website claims that its compounded semaglutide and tirzepatide are generic Ozempic and Mounjaro.
Low -
DrugsiVisitDoc, Inc. dba iVisitDoc
FDA warns iVisitDoc over website claims that compounded semaglutide is equivalent to Wegovy and Ozempic, calling the drugs misbranded.
Medium -
DrugsEli Lilly and Company
FDA says Eli Lilly’s Oprah-linked video for Zepbound and Mounjaro misled on serious risks.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's Zepbound online video omitted risk and limitations information and was not submitted to FDA.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's sponsored Zepbound video omitted risk and use information, misbranding the drug.
Low -
DrugsSomerset Therapeutics Private Limited
FDA cited Somerset Therapeutics' India plant for CGMP failures tied to a contaminated media fill and aseptic processing risks.
High risk -
FoodDingMoo LLC DBA Dingman’s Dairy
DingMoo LLC DBA Dingman’s Dairy lacked Foreign Supplier Verification Program records for imported frozen desserts and Pistachio Tartufo tied to a Salmonella outbreak.
High risk -
FoodMericon Industries, Inc.
Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.
High risk -
DrugsHikal Limited
FDA warned India's Hikal Limited that unresolved metal-particle complaints in its APIs and weak supplier oversight make its active ingredients adulterated.
High risk -
DrugsAmneal Pharmaceuticals, LLC
FDA warns Amneal over visible particles in ropivacaine injection and inadequate investigations and endotoxin lab controls.
High risk -
DrugsHomeopathic Educational Services dba Homeopathic Family Medicine
FDA says Homeopathic Family Medicine sells unapproved Cineraria Maritima Eye Drops for cataracts online.
High risk -
AnimalSynergy Animal Products, Inc.
Synergy Animal Products marketed unapproved animal drugs for dairy cows with inadequate directions and major manufacturing violations.
High risk -
DevicesMiach Orthopaedics
FDA warns Miach Orthopaedics over quality-system failures in manufacturing its BEAR ACL Implant, including sterility monitoring and nonconforming product controls.
High risk -
BiologicsInnate Healthcare Institute
FDA warned Arizona clinic Innate Healthcare Institute for selling unapproved umbilical cord stem cells marketed to treat autism.
High risk -
DevicesUscom Kft
Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.
High risk -
DevicesJiangsu Kerbio Medical Technology Group Co.
FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.
High risk -
AnimalMeds For Vets, LLC
Meds For Vets compounded unapproved animal drugs from bulk substances and failed manufacturing quality rules, including sterility controls.
High risk -
AnimalBoothwyn Pharmacy LLC
FDA warns Boothwyn Pharmacy over unapproved compounded animal drugs and falsified endotoxin records.
High risk -
DrugsConfer With
FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.
High risk -
DevicesSpectra Therapy, LLC
FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.
High risk -
DrugsShiva Analyticals Private Limited
FDA warned Shiva Analyticals, an Indian contract drug testing lab, that inadequate OOS investigations and data integrity failures adulterated tested drugs.
High risk -
DrugsMacsen Drugs
FDA cites Macsen Drugs for releasing fire-exposed APIs and inadequate stability data at India plant.
High risk -
DrugsGlenmark Pharmaceuticals Limited
FDA warns Glenmark over unresolved dissolution failures and inadequate investigations at its Pithampur, India drug plant.
High risk -
DrugsMedical Chemical Corporation
FDA warned Medical Chemical Corp over manufacturing violations, unapproved Tincture Green Soap, and improper drug listing.
High risk -
FoodIndulgeRx Brands, Inc
FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.
Medium -
DrugsEyeTech One, LLC
FDA warns EyeTech One that its EYELIVIO lubricant eye ointment is an unapproved new drug and misbranded.
Medium -
FoodShaman Botanicals, LLC
FDA warns Shaman Botanicals that its 7-OH chewable tablets are adulterated dietary supplements.
High risk -
AnimalJ.D. Heiskell Holdings LLC
J.D. Heiskell's Idaho feed mill made calf feed with too much monensin linked to calf deaths, then mixed the recalled feed into non-medicated feed.
High risk -
DevicesInsightra Medical Inc.
FDA warns Insightra Medical over unapproved IABP catheter claims and missed adverse-event reports.
High risk -
DrugsExela Pharma Sciences, LLC
Exela Pharma Sciences failed CGMP (current good manufacturing practice) for sterile injectable drugs, including invalidated sterility-media tests and inaccurate microbiology records.
High risk -
Drugswww.buynetmeds.com
FDA warned www.buynetmeds.com for selling unapproved, misbranded tapentadol and semaglutide drugs, including injectables, to U.S. consumers online.
High risk -
DrugsHealwell Homeo Private Limited
FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.
High risk -
FoodM.O.M. Enterprises, LLC
FDA warned M.O.M. Enterprises over adulterated, misbranded baby supplements and unapproved-drug claims for Gripe Water.
High risk -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
DrugsHorizon Tool Inc.
FDA warns Horizon Tool over manufacturing-rule violations for AllShield E2 Sanitizing Hand Soap.
High risk -
FoodZest US Wholesale Inc.
FDA warns Zest US Wholesale for lacking FSVP records for imported chocolate, pistachio spread, and truffle foods.
Medium -
DrugsSprout Pharmaceuticals, Inc.
FDA warned Sprout Pharmaceuticals that a CEO Instagram post for Addyi omitted risks and indication limits.
High risk -
DrugsAmerican Behavioral Research Institute, LLC
FDA warned American Behavioral Research Institute for running a 40-subject Relaxium sleep study without an IND, treating a supplement as a drug.
High risk -
TobaccoSavant Industries, LLC, d/b/a Paradigm Distribution
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded